D. E. Shaw & Co., Inc. Laboratory Corp Of America Holdings Call Options Transaction History

D. E. Shaw & Co., Inc.

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$201.05 - $221.7 $2.51 Million - $2.77 Million	-12,500 Reduced 86.21%	2,000 $402,000
Q2 2023 Aug 14, 2023	BUY	$211.93 - $241.33 $508,632 - $579,192	2,400 Added 19.83%	14,500 $3.5 Million
Q1 2023 May 15, 2023	SELL	$213.32 - $257.83 $725,288 - $876,622	-3,400 Reduced 21.94%	12,100 $2.78 Million
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $3.16 Million - $3.86 Million	15,500 New	15,500 $3.65 Million
Q1 2022 May 16, 2022	SELL	$259.82 - $298.18 $2.6 Million - $2.98 Million	-10,000 Reduced 50.0%	10,000 $2.64 Million
Q2 2020 Aug 14, 2020	SELL	$113.31 - $182.44 $702,522 - $1.13 Million	-6,200 Reduced 23.66%	20,000 $3.32 Million
Q1 2018 May 15, 2018	BUY	$161.53 - $178.11 $4.23 Million - $4.67 Million	26,200 New	26,200 $4.24 Million

126

2.48M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $19.4B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.